Search

MSK researchers recently reported results of a phase 2 trial for GIST, a rare form of gastrointestinal cancer. The trial was based on years of lab work conducted by physician-scientist Ping Chi.

… Friday, February 11, 2022 When Luis Portiansky had his first surgery in 1993 for a rare form of cancer that developed in his stomach, Ping Chi was still an undergraduate student at Mount Holyoke College in Massachusetts. More than two decades later, when Luis’ cancer came back for the third time, Dr.

… Job Title Research Fellow Degree PhD Email [email protected] Lab Phone 646-888-2649

… Kim K, Hu W, Audenet F, Almassi N … Hakimi AA, Rosenberg JE, Iyer G, Vargas HA, Scaltriti M, Al-Ahmadie H, Solit DB, Coleman JA . Modeling biological and genetic diversity in upper tract urothelial carcinoma with patient derived xenografts. Nat Commun. 2020 Apr 24;11(1):1975. doi: 10.1038/s41467-020-

… Full Title A Phase 1b/2 Study of Immune and Targeted Combination Therapies in Participants with RCC (KEYMAKER-U03) Purpose The purpose of this study is to assess the safety and effectiveness of different combinations of drugs to treat advanced clear cell renal cell carcinoma, a type of kidney cancer,

The stage of appendix cancer is determined by the size of the tumor and whether it has spread. Carcinoid tumors and carcinomas are staged differently.

… If a tumor is found, your doctor will determine its stage by judging its size and how far it has progressed. The cancer can be localized (which means it has not spread outside of the appendix), regional (spread to lymph nodes, tiny bean-shaped organs that help the body fight infections), and metastatic

Patients with inoperable advanced liver cancer have a new option for treatment to extend their lives.

… Monday, October 24, 2022 Patients with inoperable advanced liver cancer have a new option for treatment to extend their lives. Today the U.S. Food and Drug Administration (FDA) approved a combination of the immunotherapy drugs durvalumab (Imfinzi®) plus the experimental drug tremelimumab for people with

Esta información de Lexicomp® le explica lo que debe saber sobre este medicamento, por ejemplo, para qué se usa, cómo tomarlo, sus efectos secundarios y cuándo llamar a su proveedor de cuidados de la salud.

… Esta información de Lexicomp ® le explica lo que debe saber sobre este medicamento, por ejemplo, para qué se usa, cómo tomarlo, sus efectos secundarios y cuándo llamar a su proveedor de cuidados de la salud. Nombres comerciales: EE. UU. PreHevbrio [DSC] ¿Para qué se utiliza este medicamento? Este medicamento

Этот документ, предоставленный Lexicomp®, содержит всю необходимую информацию о препарате, включая показания, способ применения, побочные эффекты и случаи, при которых необходимо связаться с вашим поставщиком медицинских услуг.

… Этот документ, предоставленный Lexicomp ® , содержит всю необходимую информацию о препарате, включая показания, способ применения, побочные эффекты и случаи, при которых необходимо связаться с вашим поставщиком медицинских услуг. Торговые наименования: США PreHevbrio [DSC] Для чего используется этот

… Job Title Senior Research Technician, EXPAND Email [email protected]

… VIDEO | 2:10:31 The 2026 Clinical Genetics Patient Symposium - Inherited Cancer Syndromes: A focus on BRCA1 & BRCA2 Watch the Replay! The Clinical Genetics Service at MSK hosted a virtual symposium for patients on Inherited Cancer Syndromes in 2026: A focus on BRCA1 & BRCA2. Video Details Meet our hosts